NCT01745458View on ClinicalTrials.gov

SB-659032 Platelet Aggregation Study

PHASE1CompletedINTERVENTIONAL

Enrollment

26

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions

Atherosclerosis

Interventions

DRUG

SB-659032

DRUG

Placebo

Matched placebo

Trial Locations (1)

2031

GSK Investigational Site, Randwick, Sydney

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY